Anders Research

Anders Research

Share this post

Anders Research
Anders Research
Immix Biopharma: A Mid-To-Late Stage CAR-T Biotech Quietly Gaining Momentum

Immix Biopharma: A Mid-To-Late Stage CAR-T…

Anders Research
Sep 19, 2023
1

Share this post

Anders Research
Anders Research
Immix Biopharma: A Mid-To-Late Stage CAR-T Biotech Quietly Gaining Momentum

2024 Price Target: $13.96 (+422%)

Read →
Comments
User's avatar
© 2025 Riley Mullin
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share